This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Editorial

. 2009 Jun;1(3):507-11.

doi: 10.4155/bio.09.48.

Therapeutic drug monitoring in oncology: does it have a future?

Gillian McMahon, Robert O'Connor

PMID: 21083145
DOI: 10.4155/bio.09.48

Editorial

Therapeutic drug monitoring in oncology: does it have a future?

Gillian McMahon et al. Bioanalysis. 2009 Jun.

. 2009 Jun;1(3):507-11.

doi: 10.4155/bio.09.48.

Authors

Gillian McMahon, Robert O'Connor

PMID: 21083145
DOI: 10.4155/bio.09.48

No abstract available

PubMed Disclaimer

Similar articles

X chemotherapy, myth and realities.
Thomas M, Pavithran K. Thomas M, et al. J Indian Med Assoc. 2005 Sep;103(9):489-90, 492, 494. J Indian Med Assoc. 2005. PMID: 16493871
Laboratory monitoring in oncology.
Duong CD, Loh JY. Duong CD, et al. J Oncol Pharm Pract. 2006 Dec;12(4):223-36. doi: 10.1177/1078155206072982. J Oncol Pharm Pract. 2006. PMID: 17156594 Review.
Therapeutic Drug Monitoring in Oncology.
Wilkinson DS. Wilkinson DS. Ther Drug Monit. 2019 Oct;41(5):551-552. doi: 10.1097/FTD.0000000000000679. Ther Drug Monit. 2019. PMID: 31318845 No abstract available.
"Therapeutic intent" in phase 1 oncology trials: a justifiable objective.
Markman M. Markman M. Arch Intern Med. 2006 Jul 24;166(14):1446-8. doi: 10.1001/archinte.166.14.1446. Arch Intern Med. 2006. PMID: 16864753 Review. No abstract available.
Cracking the mild, difficult and fiendish codes within and downstream of the EGFR to link diagnostics and therapeutics.
Waterfield M. Waterfield M. Biochem Soc Trans. 2007 Feb;35(Pt 1):1-6. doi: 10.1042/BST0350001. Biochem Soc Trans. 2007. PMID: 17212578 Review.

See all similar articles

Cited by

Potential of Surface Enhanced Raman Spectroscopy (SERS) in Therapeutic Drug Monitoring (TDM). A Critical Review.
Jaworska A, Fornasaro S, Sergo V, Bonifacio A. Jaworska A, et al. Biosensors (Basel). 2016 Sep 19;6(3):47. doi: 10.3390/bios6030047. Biosensors (Basel). 2016. PMID: 27657146 Free PMC article. Review.
Practical guidelines for therapeutic drug monitoring of anticancer tyrosine kinase inhibitors: focus on the pharmacokinetic targets.
Yu H, Steeghs N, Nijenhuis CM, Schellens JH, Beijnen JH, Huitema AD. Yu H, et al. Clin Pharmacokinet. 2014 Apr;53(4):305-25. doi: 10.1007/s40262-014-0137-2. Clin Pharmacokinet. 2014. PMID: 24566736 Review.
Reduced Graphene Oxide and Gold Nanoparticles-Modified Electrochemical Aptasensor for Highly Sensitive Detection of Doxorubicin.
Kong F, Luo J, Jing L, Wang Y, Shen H, Yu R, Sun S, Xing Y, Ming T, Liu M, Jin H, Cai X. Kong F, et al. Nanomaterials (Basel). 2023 Mar 30;13(7):1223. doi: 10.3390/nano13071223. Nanomaterials (Basel). 2023. PMID: 37049316 Free PMC article.
Shortwave Infrared-Emitting Theranostics for Breast Cancer Therapy Response Monitoring.
Shah JV, Gonda A, Pemmaraju R, Subash A, Bobadilla Mendez C, Berger M, Zhao X, He S, Riman RE, Tan MC, Pierce MC, Moghe PV, Ganapathy V. Shah JV, et al. Front Mol Biosci. 2020 Oct 6;7:569415. doi: 10.3389/fmolb.2020.569415. eCollection 2020. Front Mol Biosci. 2020. PMID: 33134314 Free PMC article.
Polyrhodanine-based nanomaterials for biomedical applications: A review.
Hiba IH, Koh JK, Lai CW, Mousavi SM, Badruddin IA, Hussien M, Wong JP. Hiba IH, et al. Heliyon. 2024 Apr 8;10(7):e28902. doi: 10.1016/j.heliyon.2024.e28902. eCollection 2024 Apr 15. Heliyon. 2024. PMID: 38633652 Free PMC article. Review.

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions

LinkOut - more resources

Full Text Sources
- Atypon
- Ovid Technologies, Inc.